Axomove, a pioneering digital health player focused on prevention and rehabilitation and a Faraday Venture Partners portfolio company since 2022, announces a €4 million Series A round. The transaction, co-led by the Digital Prevention Fund managed by Bpifrance and Go Capital, together with Inco Ventures, will drive the commercial rollout of the solution and its scaling in the market.
As a historical investor, Faraday is reinforcing its commitment to Axomove in this new growth phase, supporting the company in consolidating its model and expanding its reach within the healthcare ecosystem.
The funds raised will be allocated to three strategic priorities:
• Driving commercial development across corporate, insurance and healthcare provider segments
• Expanding reimbursement coverage to new musculoskeletal conditions and metabolic diseases, with a focus on obesity
• Advancing the technological platform to enhance user experience through advanced motion capture and gamification features
Since its launch in 2019, Axomove has demonstrated strong execution and meaningful market traction. The company currently has 150 clients across hospitals, corporations and insurers—including Air France, Thales, Allianz, Alliance Klesia-Generali, CHU de Lille and Ramsay Santé—representing 75,000 users. Its solution is already reimbursed by the French Social Security for patients with lower back pain. Axomove has a team of 30 professionals and plans to double its workforce over the next three years.
“The confidence of leading institutional investors validates the relevance of our strategy and reinforces our ambition to become a standard of care in prevention and rehabilitation,” said Boris Lévêque, Co-founder and CEO of Axomove
“Since our entry in 2022, Axomove has demonstrated very strong execution capabilities, validating its proposition both clinically and commercially. The combination of a digital solution and healthcare support is effectively addressing a structural issue such as musculoskeletal disorders, with tangible impact on patients and companies. The project’s evolution, together with the quality of the team and their ambition, reinforces our conviction to continue supporting them in this new phase of growth,” said Gonzalo Tradacete, CEO and Founder of Faraday Venture Partners.
Musculoskeletal disorders currently affect one in two adults in France. Following a hospital episode, Axomove provides a personalized care pathway that combines digital support with follow-up by healthcare professionals. Its adoption is supported by measurable clinical benefits for patients—doubling functional capacity and a fivefold increase in treatment adherence—as well as significant economic and social benefits: a 50% reduction in absenteeism and a threefold decrease in healthcare costs. These indicators confirm the value created by Axomove for patients, employers and the broader healthcare system.
cloud technology axon
Thanks to the support of CDTI Innovación, the Catalan company Abrasto...
